The World Health Organization has recommended the use of a second malaria vaccine to curb the spread of the life-threatening disease
The World Health Organization has recommended the use of a second malaria vaccine to curb the spread of the life-threatening disease
The vaccine, know as R21/Matrix-M, is developed by Britain's University of Oxford, will become available by mid-2024
R21/Matrix-M is mass manufactured by Serum Institute of India and uses Novavax's Matrix M adjuvant
Adar Poonawalla, CEO of Serum Institute of India, said it had already produced more than 20 million doses in anticipation of WHO's recommendation
The vaccine will compete against the RTS,S shot by GSK Plc , which was recommended by the United Nations-agency in 2021 and sold under the brand Mosquirix
The vaccine will compete against the RTS,S shot by GSK Plc , which was recommended by the United Nations-agency in 2021 and sold under the brand Mosquirix